The CPD Register Logo
Managing Quality of Health Products Throughout the Supply Chain
CPD Webinar The CPD Group - Webinars

Managing Quality of Health Products Throughout the Supply Chain

Accredited With: The CPD Group
Accreditation Number: #501303
Provider: #788925
CPD Credits: 2 Credits
Duration: 90 Minutes
Accredited: 19 Aug 2026 → 19 Aug 2029 ACTIVE

About This Webinar

A medicine that was approved, procured, and dispatched in full compliance with regulatory requirements can still reach a patient in a degraded, adulterated, or ineffective state. That failure is not theoretical — it is a documented, measurable, and a recurring feature of health supply chains across Africa, with direct consequences for patient outcomes, health system trust, and the professionals who work within those systems.
A 2024 systematic review analysing 27 studies across the African continent found that 22.6% of medicine samples failed quality tests and were confirmed to be substandard or falsified — almost one in four. The same review found the average prevalence of unregistered medicines to be 34.6%. The World Health Organization (WHO) estimates that in low- and middle-income countries, 1 in 10 medicines circulating in the market are substandard or falsified, with all regions seeing an increase according to its 2024 Global Surveillance and Monitoring System report.
In South Africa specifically, quality complaint reports filed with the South African Health Products Regulatory Authority (SAHPRA) rose from 101 in 2021/22 to 297 in 2022/23 — nearly tripling in one year — and reached 588 reports of possible non-compliance in 2024/25.

Regulatory progress is being made. As of September 2025, nine African countries — Egypt, Ethiopia, Ghana, Nigeria, Rwanda, Senegal, South Africa, Tanzania, and Zimbabwe — have achieved WHO Global Benchmarking Tool (GBT) Maturity Level 3 (ML3), signifying a stable, well-functioning, and integrated regulatory system. However, ML3 status does not automatically resolve the quality failures that occur downstream of regulatory approval. The GBT, as currently structured, does not fully capture the regulatory responsibilities that apply to supply chain logistics providers — the freight forwarders, transporters, clearing agents, and last-mile distributors through whom falsified or substandard products most frequently enter the market. That gap between regulatory gatekeeping and supply chain implementation is the core problem this webinar series addresses.

Post-marketing surveillance — the mechanism by which regulatory authorities monitor product quality after market entry — remains underfunded and fragmented across the continent. Despite progress in pre-market regulatory functions, data and capacity for post-market monitoring continue to lag behind, leaving large portions of the in-country supply chain effectively unmonitored.

This webinar initiative is a result of a collaborative planning process involving Bee Skilled, SAPICS, CMCOMMS, the Ecumenical Pharmaceutical Network (EPN), and the International Association of Public Health Logisticians (IAPHL).

The shared diagnosis across all partners is that the field needs not just awareness, but structured, evidence-based professional dialogue that connects global regulatory standards to on-the-ground practice — and that produces tangible, transferable learning for the supply chain workforce.

Summary

Across Africa, medicines that are approved, procured, and dispatched can still reach patients substandard, falsified, or entirely ineffective. This webinar series provides the evidence base: what poor-quality medical products actually are, the scale of the problem across the continent and goes deep into functions within supply chain that has the potential to affect product quality.
Drawing on published surveillance data and a panel of practitioners from East, West, and Southern Africa, the webinar examines the regulatory, supply chain, and market-level root causes — and the patient and economic consequences when those failures go undetected and unaddressed.

Share This Page

Webinar Details

CPD Credits

2 Credits

CPD duration

90 minutes

Accreditation Number

#501303

Accredited With

The CPD Group

Status

✓ ACTIVE

Valid until 19 Aug 2029

Accredited Since

19 Aug 2026

Back to Search